LOGIN  |  REGISTER
Cue Biopharma
Surmodics

Apyx Medical to Participate in Upcoming Investor Conferences in November

November 07, 2023 | Last Trade: US$1.30 0.00 0.00

CLEARWATER, Fla. / Nov 07, 2023 / Business Wire / Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences:

The Stephens Annual Investment Conference at the Nashville Grand Hyatt in Nashville, TN

  • Management will participate in a fireside chat on Tuesday, November 14 at 12:00 p.m. Eastern Time.

The Craig-Hallum 14th Annual Alpha Select Conference at the Sheraton NY Times Square Hotel in New York, NY

  • Management will participate in 1x1 meetings on Thursday, November 16. There will be no formal presentation.

The Piper Sandler 35th Annual Healthcare Conference at the Lotte New York Palace in New York, NY

  • Management will participate in a fireside chat on Wednesday, November 29 at 4:00 p.m. Eastern Time.

Audio webcasts of the fireside chat will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. The webcasts will be achieved and available for replay following the conferences.

About Apyx Medical Corporation

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Recursion

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB